Imperial College London
Portrait Picture

Prof. Diana Gorog

Faculty of Medicine, National Heart & Lung Institute

Honorary Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7034 8934d.gorog

 
 
//

Location

 

Royal BromptonRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Piccini:2022:10.1016/S0140-6736(22)00456-1,
author = {Piccini, JP and Caso, V and Connolly, SJ and Fox, KAA and Oldgren, J and Jones, WS and Gorog, DA and Durdil, V and Viethen, T and Neumann, C and Mundl, H and Patel, MR},
doi = {10.1016/S0140-6736(22)00456-1},
journal = {LANCET},
pages = {1383--1390},
title = {Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study},
url = {http://dx.doi.org/10.1016/S0140-6736(22)00456-1},
volume = {399},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Piccini,JP
AU  - Caso,V
AU  - Connolly,SJ
AU  - Fox,KAA
AU  - Oldgren,J
AU  - Jones,WS
AU  - Gorog,DA
AU  - Durdil,V
AU  - Viethen,T
AU  - Neumann,C
AU  - Mundl,H
AU  - Patel,MR
DO  - 10.1016/S0140-6736(22)00456-1
EP  - 1390
PY  - 2022///
SN  - 0140-6736
SP  - 1383
TI  - Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
T2  - LANCET
UR  - http://dx.doi.org/10.1016/S0140-6736(22)00456-1
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000812839300022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 399
ER  -
Download